These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 2685127)

  • 1. Escherichia coli virulence and renal scarring.
    Topley N; Mackenzie RK; Steadman R; Williams JD
    J Infect Dis; 1989 Dec; 160(6):1081-3. PubMed ID: 2685127
    [No Abstract]   [Full Text] [Related]  

  • 2. Properties of Escherichia coli in patients with renal scarring.
    Lomberg H; Hellström M; Jodal U; Orskov I; Svanborg Edén C
    J Infect Dis; 1989 Mar; 159(3):579-82. PubMed ID: 2644385
    [No Abstract]   [Full Text] [Related]  

  • 3. Renal scarring and non-attaching Escherichia coli.
    Lomberg H; Hellström M; Jodal U; Svanborg-Edén C
    Lancet; 1986 Dec; 2(8519):1341. PubMed ID: 2878215
    [No Abstract]   [Full Text] [Related]  

  • 4. Renal scarring by mannose-sensitive adhesin of Escherichia coli type 1 pili.
    Mizunoe Y; Matsumoto T; Sakumoto M; Kubo S; Mochida O; Sakamoto Y; Kumazawa J
    Nephron; 1997; 77(4):412-6. PubMed ID: 9434062
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Type 1 fimbriate strains of Escherichia coli initiate renal parenchymal scarring.
    Topley N; Steadman R; Mackenzie R; Knowlden JM; Williams JD
    Kidney Int; 1989 Oct; 36(4):609-16. PubMed ID: 2572719
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Experimental pyelonephritis in the cat. 1. Gross and histological changes.
    Kelly DF; Lucke VM; McCullagh KG
    J Comp Pathol; 1979 Jan; 89(1):125-39. PubMed ID: 370162
    [No Abstract]   [Full Text] [Related]  

  • 7. Clinical pyelonephritis and focal renal scarring. A selected review of pathogenesis, prevention, and prognosis.
    Winberg J; Bollgren I; Källenius G; Möllby R; Svenson SB
    Pediatr Clin North Am; 1982 Aug; 29(4):801-14. PubMed ID: 6125926
    [No Abstract]   [Full Text] [Related]  

  • 8. Host response to porcine strains of Escherichia coli in a novel pyelonephritis model.
    Isling LK; Aalbæk B; Birck MM; Heegaard PM; Leifsson PS
    J Comp Pathol; 2011 May; 144(4):257-68. PubMed ID: 21159351
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Histological changes in the murine kidney in experimental hematogenic pyelonephritis from E. coli strains isolated from different sources].
    Bakŭrdzhiev T; Marinova R
    Eksp Med Morfol; 1981; 20(4):237-42. PubMed ID: 7035136
    [No Abstract]   [Full Text] [Related]  

  • 10. [Studies on the route of infection in experimental coli pyelonephritis].
    Sack K; Freiesleben H; Wöhrmann W; Henkel W; Commichau R
    Virchows Arch A Pathol Pathol Anat; 1972; 355(4):323-32. PubMed ID: 4625543
    [No Abstract]   [Full Text] [Related]  

  • 11. Escherichia coli in patients with renal scarring: genotype and phenotype of Gal alpha 1-4Gal beta-, Forssman- and mannose-specific adhesins.
    Plos K; Lomberg H; Hull S; Johansson I; Svanborg C
    Pediatr Infect Dis J; 1991 Jan; 10(1):15-9. PubMed ID: 1672231
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Case records of the Massachusetts General Hospital. Weekly clinicopathological exercises. Case 31-1985. A 43-year-old man with nine years of fever of unknown origin.
    N Engl J Med; 1985 Aug; 313(5):312-8. PubMed ID: 3892298
    [No Abstract]   [Full Text] [Related]  

  • 13. Etiology of pyelonephritis: further evidence associating the production of experimental pyelonephritis with hemolysis in Escherichia coli.
    Fried FA; Vermeulen CW; Ginsburg MJ; Cone CM
    J Urol; 1971 Sep; 106(3):351-4. PubMed ID: 4938270
    [No Abstract]   [Full Text] [Related]  

  • 14. [Pathomorphologic characteristics of hematogenous colibacillary pyelonephritis in rats].
    Starkov MV; Boguslavskaia ES; Lisitsa LI
    Biull Eksp Biol Med; 1973 Mar; 75(3):111-4. PubMed ID: 4614869
    [No Abstract]   [Full Text] [Related]  

  • 15. An ascending non-obstructive model for chronic pyelonephritis in BALB/c mice.
    Gupta R; Ganguly NK; Ahuja V; Joshi K; Sharma S
    J Med Microbiol; 1995 Jul; 43(1):33-6. PubMed ID: 7608952
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Pathomorphologic characteristics of hematogenous colibacillary pyelonephritis in rats].
    Starkov MV; Boguslavskaia ES; Lisitsa LI
    Biull Eksp Biol Med; 1973 Mar; 75(1):111-4. PubMed ID: 4591625
    [No Abstract]   [Full Text] [Related]  

  • 17. Immunization against retrograde pyelonephritis. III. Vaccination against chronic pyelonephritis due to Escherichia coli.
    Brooks SJ; Lyons JM; Braude AI
    J Infect Dis; 1977 Nov; 136(5):633-9. PubMed ID: 335001
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of antioxidant defence, renal toxicity markers and inflammatory cascade in disease progression of acute pyelonephritis in experimental rat model.
    Vysakh A; Raji NR; Suma D; Jayesh K; Jyothis M; Latha MS
    Microb Pathog; 2017 Aug; 109():189-194. PubMed ID: 28578087
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [An experimental model of ascending pyelonephritis in rats].
    Chilimoniuk M; Jodczyk JK; Dzierzanowska D; Musierowicz A; Korfel Z
    Med Dosw Mikrobiol; 1977; 29(1):67-71. PubMed ID: 323605
    [No Abstract]   [Full Text] [Related]  

  • 20. Antioxidant effect on renal scarring following infection of mannose-sensitive-piliated bacteria.
    Matsumoto T; Mitzunoe Y; Ogata N; Tanaka M; Takahashi K; Kumazawa J
    Nephron; 1992; 60(2):210-5. PubMed ID: 1348108
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.